IP Library Granted Patent US 7,432,252
Granted Patent B1
US 7,432,252 · App. 09/531,851 · Granted Oct 7, 2008

Method of promoting cervical and vaginal secretions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,432,252
App. No.
09/531,851
Granted
Oct 7, 2008
Kind
B1
Abstract

The present invention provides a method of stimulating cervical and vaginal secretions in a mammal by treatment with P2Y 2 and/or P2Y 4 purinergic receptor agonists. Treatment of vaginal dryness associated with menopause, chemotherapy, and various disease states as well as the treatment of vulvar pain is discussed. Suitable agonists such as UTP, CTP, ATP, dinucleotides and analogs thereof are disclosed.

Claims (6)

1. A method of stimulating cervical and vaginal secretions in a mammal in need thereof by administering an effective secretion stimulating amount of a compound of P 1 , P 4 -di(uridine 5′-) tetraphosphate to a mammal in need thereof.

2. A method of treating a mammal with vaginal dryness by administering an effective vaginal treatment amount of a compound of P 1 , P 4 -di(uridine 5′-) tetraphosphate to a mammal in need thereof.

3. The method according to claim 2 , wherein said compound is topically administered to the cervical or vaginal mucosa of the mammal in a form of a solution, gel, suspension, cream, foam, ointment, pessary, or tablet.

4. The method according to claim 2 , wherein said compound is systemically administered to the mammal.

5. The method of claim 2 , wherein the amount of the compound administered to the mammal is sufficient to achieve a concentration on the cervical and/or vaginal mucosa of from about 10 −7 moles/liter to about 10 −1 moles/liter.

6. The method of claim 2 , wherein the amount of the compound administered to the mammal is sufficient to achieve a daily dose of between 1 to 1000 milligrams.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2015
From: INSPIRE PHARMACEUTICALS, INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 034863/0372 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2002
From: YERXA, BENJAMIN R.
To: INSPIRE PHARMACEUTICALS, INC.
Reel/Frame 012741/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2000
From: PENDERGAST, WILLIAM; SHAVER, SAMMY R.; DRUTZ, DAVID J.; RIDEOUT, JANET L.
To: INSPIRE PHARMACEUTICALS, INC.
Reel/Frame 010956/0769 →